The most common treatment-related adverse events were leukopenia (61.1%), neutropenia (52.8%), fatigue (50.0%), numbness (44.4%), AST elevation (30.6%) and ALT elevation (27.8%). Here, GPT is linked to Decreased total leukocyte count.